Selvita Strengthens Sales & Drug Development Management
10 Dec 2024 //
PR NEWSWIRE
Selvita Reports Strong H2 2024 Recovery, Sees Promising Outlook
21 Nov 2024 //
PR NEWSWIRE
Selvita Reports Growing Sales Projects Higher H2 Profitability
24 Sep 2024 //
PR NEWSWIRE
Selvita Expands Capabilities With PozLab Acquisition
07 May 2024 //
PR NEWSWIRE
Selvita launches biologic drug discovery and development services
18 Mar 2024 //
PR NEWSWIRE
Selvita Q1 2023 financial results exceed initial estimates
31 May 2023 //
PR NEWSWIRE
Selvita`s growth continues with completion of new Krakow HQ
29 Mar 2023 //
FIERCE BIOTECH
Selvita Joins Scientist.com’s IND Package Pipeline Program
28 Mar 2023 //
BUSINESSWIRE
Selvita continues to scale operations with the completion of new research centre
27 Mar 2023 //
PR NEWSWIRE
Selvita exceeds its development strategy assumptions
06 Sep 2022 //
PRNEWSWIRE
Selvita appoints Dean Bornilla as Vice President of Sales, Head of North America
19 Jul 2021 //
PR NEWSWIRE
Selvita scales its operations with the construction of new research space
12 Jul 2021 //
PRNEWSWIRE
Selvita scales its operations with the construction of new research space
12 Jul 2021 //
PRNEWSWIRE
Selvita scales its operations with the construction of new research space
12 Jul 2021 //
PRNEWSWIRE
Selvita completes acquisition of Fidelta from Galapagos
04 Jan 2021 //
BIOSPACE
Selvita Raised Over EUR 20 Million in Its Follow-on Public Offer
03 Jun 2020 //
PRNEWSWIRE
Selvita Extraordinary General Shareholder Meeting Decides to Proceed
26 May 2020 //
PR NEWSWIRE